Cargando…
Association of prolactin receptor (PRLR) variants with prolactinomas
Prolactinomas are the most frequent type of pituitary tumors, which represent 10–20% of all intracranial neoplasms in humans. Prolactinomas develop in mice lacking the prolactin receptor (PRLR), which is a member of the cytokine receptor superfamily that signals via Janus kinase-2-signal transducer...
Autores principales: | Gorvin, Caroline M, Newey, Paul J, Rogers, Angela, Stokes, Victoria, Neville, Matt J, Lines, Kate E, Ntali, Georgia, Lees, Peter, Morrison, Patrick J, Singhellakis, Panagiotis N, Malandrinou, Fotini Ch, Karavitaki, Niki, Grossman, Ashley B, Karpe, Fredrik, Thakker, Rajesh V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400049/ https://www.ncbi.nlm.nih.gov/pubmed/30445560 http://dx.doi.org/10.1093/hmg/ddy396 |
Ejemplares similares
-
Identification of prolactin receptor variants with diverse effects on receptor signalling
por: Gorvin, Caroline M, et al.
Publicado: (2022) -
Targeting Prolactin Receptor (PRLR) Signaling in PRLR-Positive Breast and Prostate Cancer
por: O’Sullivan, Ciara C., et al.
Publicado: (2016) -
Prolactin Receptor (PRLR) Isoform Expression in the Murine Oviduct
por: Radecki, Kelly C, et al.
Publicado: (2021) -
Natural and molecular history of prolactinoma: insights from a Prlr
(–/–) mouse model
por: Bernard, Valérie, et al.
Publicado: (2017) -
A novel bispecific antibody targeting CD3 and prolactin receptor (PRLR) against PRLR-expression breast cancer
por: Zhou, Yuexian, et al.
Publicado: (2020)